Portfolio of Medical Diagnostic Stocks
Here are 13 companies that offer medical diagnostic products.
|13 Medical Diagnostic Stocks|
Stock Returns & Price Chart
Recent Prices &
|Oxford Immunotec Global PLC||OXFD|
|Trinity Biotech plc||TRIB|
|Price data from Quandl as of most recent close.|
To inspect the performance of the Medical Diagnostic Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.The 12 stocks included in the portfolio computations are: AXDX, EXAS, IDXX, VIVO, MYGN, NAVB, NEOG, OPK, QGEN, QDEL, SRDX and TRIB. The current value of the portfolio assumes that $833.33 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. OXFD was excluded from the portfolio computations because of insufficient price data.
The current value of a $10,000 investment is $66,370. The percent return is 563.70%. The annualized return is 20.84%.
|Return Summary for Medical Diagnostic Stocks|
|Current Value of Investment||$66,369.95|
|Number Profitable Returns||6,680|
|Percent Profitable Returns||92.01%|
|Number Unprofitable Returns||580|
|Percent Unprofitable Returns||7.99%|
|Profitable to Unprofitable Returns Ratio||11.52|
NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.